Healthcare icons on top of high tech background

health care icon pattern medical innovation concept background design

Pharmacy Industry Updates: January 2020

Every month, our Industry Relations Director, LeAnn Lewis provides an in-depth industry update to customers. Below, you will find an agenda for the industry update for January. If you have any questions regarding any of the points, contact us here.


PDMP Updates
  • Nebraska – Posted New Data Submission Guide V1.2.1 on 11-13-2019
  • Oregon – Effective likely 01-01-2020 (still waiting on final rule)
    • Require Gabapentin Reporting as a Drug of Concern
    • Require Diagnosis Code and “reason for the prescription” if provided on the prescription
  • California
    • New format of the 12-digit Serial Number was published for 1-1-20
    • 01-01-2021 -Require reporting “as soon as reasonably possible but no more than one working day after a controlled substance is dispensed.” Also requires Schedule V reporting.
  • Florida – ASAP V4.2A Accepted now, but required as of 12-19-2019
  • Pennsylvania – Effective 02-28-2020 will require submission of
    • Patient Phone Number (PAT17)
    • NCPDP ID field (PHA02)
    • Transmission Form of Rx Origin Code (DSP12)
    • Partial Fill Indicator (DSP13)
    • Prescriber State License Number (PRE04) when available)
    • New Data Submission Guide is available
  • Utah – Will be moving to NIC’s RxGov in the future
    • 11-19-2019 – Tentatively scheduled for late December, early January


Legislative/Regulatory Reminders for January 2020
  • Electronic Prescribing of Controlled Substances 01-01-2020
    • Arizona, Iowa (ALL), Massachusetts, North Carolina, Oklahoma, Rhode Island
  • Controlled Substances/Opioids
    • Massachusetts – Allow incremental filling of Schedule II, dispensing of Naloxone
    • Delaware – Opioids Impact Fund Fee
    • New Hampshire – Orange “Opioid” sticker, “Risk of addiction and overdose” warning label and Handout
    • Texas – Notification of safe disposal on all Schedule II scripts; new Opioid prescribing
    • Nevada – New opioid prescribing limits
    • Tennessee – Allow Incremental filling of Schedule II
  • Requirements to check PDMP
    • Massachusetts, Nevada
  • Pharmacy Practice
    • Compounding – California, Connecticut
    • Pharmacist Prescriptive Authority – California, Maryland, Montana
    • Telepharmacy – Iowa, Texas
    • Oregon – require notification of prescription reader for visually impaired
  • Licensing or Continuing Education Requirements
    • California, Alabama, Iowa, Texas, West Virginia
  • PBM Requirements Everything from audit requirements, gag clauses, out of pocket limits, anti-steering and network requirements, to can’t charge retroactive fees
    • Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Montana, New York, Texas, Virginia
New Legislative/Regulatory Highlights
  • Texas – New limits on Opioid Prescriptions
  • Montana – Can administer immunizations to 7 years of age and above
  • Oregon – Allows pharmacist prescribing of insulin under certain circumstances and protocols
Get Involved/Get Informed Spotlight
    • Network compliance information
  • 2019 Legislative/Regulatory Highlights


Contact us to ask questions or get more information about these updates.

Bio and photo of Leann Lewis


The organizer of this call is not an attorney, and the presentation on this call does not constitute legal advice.  It contains only the opinions and observations of the organizer and its participants.  Any use of information contained in this presentation is at the user’s own risk. The organizer will not be available for depositions or testimony in case of litigation.

Leave a Reply

Your email address will not be published. Required fields are marked *